Redeye shares its initial impressions of NextCell’s recently announced collaboration with Fujifilm I...
Redeye comments on Embracer’s Q4-results which saw stronger-than-expected EBIT, driven by PC/Console...
Redeye comments on Better Collective’s Q1-results which were somewhat better than expected as revenu...
Redeye updates its view on Flexion Mobile following its Q1 2025 report, which was in line with our e...
Q1 revenues 3% below, EBIT DKK -1m vs. ABGSCe DKK 11m FY'25 guidance maintained, as expected Consens...
Fiskars hosted its "Get to know Vita" day today. The company has been building its "brand first" app...
Redeye comments on Flexion Mobile's Q1 2025 report, which was pretty much in line with expectations.
Redeye believes Lagercrantz continued its stable trend and ended fiscal year 2024/2025 in a solid fa...
Redeye is satisfied with TO12's preliminary subscription rate of 71%.
För det första kvartalet 2025 var intäkterna 39 procent lägre än Mangolds prognos.
Redeye returns with a more in-depth take on the Q1 earnings.
Utifrån en fortsatt svag marknad och orderingång under början av 2025 har vi sänkt våra förväntninga...
Redeye retains its positive view of Lagercrantz after a Q4 report that aligned with our projections.
Underliggande tillväxt trots svagare kvartal Det första kvartalet var sammantaget svagare än motsva...
Redeye reiterates its fair value range following Dala Energi’s Q1 report that was published last Fri...
Redeye comments on Initiator Pharma’s announcements earlier today regarding its clinical expansion i...
Nettoomsättningen för det första kvartalet uppgick till 8,2 MEURO (10,9), vilket motsvarade en minsk...
Biofrigas Sweden AB (publ) (”Biofrigas” eller ”Bolaget”) är verksamma på den växande marknaden för f...
No real progress in Q1 Market to turn positive in '25e, according to report Turnaround delayed, '25e...
Q1 sales +40% y-o-y, +2% q-o-q, FCF negative Cut '25e-'27e sales by 7% on weaker Q2 outlook Market r...
